Remove Bioinformatics Remove Disease Remove Research Remove Workshop
article thumbnail

Big data – charting a new path to drug discovery and development

Drug Discovery World

While the potential for better insights has grown, acquiring powerful tools that can harness that data, and turn it into useful, actionable information, has increasingly become one of the most important aspects of life science research. Yet there is no denying that these powerful tools have ground-breaking impacts in other industries.

Science 100
article thumbnail

A new viral surveillance system in West Africa is showing the world how to prevent the next pandemic

Broad Institute

He started to imagine how the deadly and contagious disease, if confirmed, might spread to half the city’s population. Eight of the 20 patients died, but the spread of the disease in Nigeria stopped there. Partnering with researchers on the ground to reach communities where they are is absolutely critical to making that a reality.” “We

Virus 132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article FDA Thank You Leaders at FDA share highlights and updates for drugs and biologics at RAPS Convergence

Agency IQ

Leaders at FDA share highlights and updates for drugs and biologics at RAPS Convergence Top officials from FDA’s Centers for drugs and biologics—including Center for Biologics Evaluation and Research (CBER) Director Peter Marks—provided high-level updates at RAPS Convergence 2023 this week.

FDA 40
article thumbnail

A scientist devotes her career to tackling inequity in genomics

Broad Institute

Credit: Allison Colorado, Broad Communications Arriving in the Bay Area after a childhood in increasingly diverse surroundings, Martin became acutely aware of health disparities and the profound differences in disease prevalence among different populations. I wanted to know how I could have any impact on studying genetic diversity.”

article thumbnail

Is That DNA Dangerous?

Codon

A concerned employee at a laboratory supply company had called the Centers for Disease Control, or CDC, after fielding repeated calls from Harris asking when his samples of plague would arrive in the mail. Starting in October, researchers receiving funds from the U.S. Bioinformatic results from SecureDNA.

DNA 80
article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

It has made its way into almost every aspect of drug discovery, whether it’s exploring basic biology, modelling diseases, identifying and validating targets, or performing drug screens. . This process can be drawn-out, expensive, and time and resource-intensive, often slowing down the momentum of a research study. .

DNA 246